LNTH vs. RIOT, NEOG, QDEL, CLDX, NTLA, MYGN, BBIO, MDGL, NUVL, and MMSI
Should you be buying Lantheus stock or one of its competitors? The main competitors of Lantheus include Riot Platforms (RIOT), Neogen (NEOG), QuidelOrtho (QDEL), Celldex Therapeutics (CLDX), Intellia Therapeutics (NTLA), Myriad Genetics (MYGN), BridgeBio Pharma (BBIO), Madrigal Pharmaceuticals (MDGL), Nuvalent (NUVL), and Merit Medical Systems (MMSI).
Riot Platforms (NASDAQ:RIOT) and Lantheus (NASDAQ:LNTH) are both mid-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, community ranking, dividends, earnings, institutional ownership and analyst recommendations.
Riot Platforms received 168 more outperform votes than Lantheus when rated by MarketBeat users. Likewise, 67.21% of users gave Riot Platforms an outperform vote while only 65.20% of users gave Lantheus an outperform vote.
In the previous week, Riot Platforms had 4 more articles in the media than Lantheus. MarketBeat recorded 19 mentions for Riot Platforms and 15 mentions for Lantheus. Riot Platforms' average media sentiment score of 0.58 beat Lantheus' score of 0.47 indicating that Lantheus is being referred to more favorably in the news media.
Lantheus has higher revenue and earnings than Riot Platforms. Riot Platforms is trading at a lower price-to-earnings ratio than Lantheus, indicating that it is currently the more affordable of the two stocks.
40.3% of Riot Platforms shares are held by institutional investors. Comparatively, 99.1% of Lantheus shares are held by institutional investors. 4.4% of Riot Platforms shares are held by company insiders. Comparatively, 1.5% of Lantheus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Riot Platforms presently has a consensus price target of $18.87, suggesting a potential upside of 58.86%. Lantheus has a consensus price target of $104.71, suggesting a potential upside of 60.58%. Given Riot Platforms' higher possible upside, analysts plainly believe Lantheus is more favorable than Riot Platforms.
Lantheus has a net margin of 25.20% compared to Lantheus' net margin of -17.62%. Riot Platforms' return on equity of 63.16% beat Lantheus' return on equity.
Riot Platforms has a beta of 4.25, meaning that its share price is 325% more volatile than the S&P 500. Comparatively, Lantheus has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500.
Summary
Lantheus beats Riot Platforms on 10 of the 18 factors compared between the two stocks.
Get Lantheus News Delivered to You Automatically
Sign up to receive the latest news and ratings for LNTH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LNTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Lantheus Competitors List
Related Companies and Tools
